MEMG

Stempeutics out licenses its novel stem cell product “Stempeucel-DFU” to Cipla for treating non healing Diabetic Foot Ulcer (DFU)

Diabetic foot is one of the most significant and devastating complications of diabetes Out of approx. 70 million diabetics in India,…

5 years ago

Manipal Education & Medical Group (MEMG) Appoints Mr. Subrat Mohanty as Group President

New Delhi, June 08, 2019: Manipal Education & Medical Group (MEMG), a privately held conglomerate focused on education, healthcare and…

5 years ago

Cigna TTK Health Insurance receives IRDAI approval to partner with Manipal Group

Manipal Group and TTK Group will jointly hold 51% stake in the health insurance venture Cigna Corporation will continue to…

6 years ago

Alkem Laboratories inks out-licensing Treat Stempeutics Research

Mumbai, February 10, 2018:  Pharma Major Alkem Laboratories has inked an out-licensing deal with Stempeutics Research, a group company of…

7 years ago